GI
OFIX icon

GAMMA Investing’s Orthofix Medical OFIX Stock Holding History

GAMMA Investing’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.29K Buy
987
+469
+91% +$4.83K ﹤0.01% 3381
2026
Q2 		$4.74K Sell
518
-804
-61% -$8.87K ﹤0.01% 3491
2026
Q1 		$15.2K Buy
1,322
+469
+55% +$6.19K ﹤0.01% 2864
2025
Q4 		$12.9K Buy
853
+356
+72% +$5.43K ﹤0.01% 2857
2025
Q3 		$7.28K Sell
497
-400
-45% -$5.25K ﹤0.01% 3028
2025
Q2 		$10K Sell
897
-505
-36% -$6.26K ﹤0.01% 2804
2025
Q1 		$22.9K Buy
1,402
+45
+3% +$790 ﹤0.01% 2314
2024
Q4 		$23.7K Buy
1,357
+167
+14% +$2.9K ﹤0.01% 2184
2024
Q3 		$18.6K Buy
1,190
+147
+14% +$2.35K ﹤0.01% 2148
2024
Q2 		$13.8K Sell
1,043
-255
-20% -$3.49K ﹤0.01% 2066
2024
Q1 		$18.8K Buy
1,298
+36
+3% +$498 ﹤0.01% 1691
2023
Q4 		$17.5K Buy
+1,262
New +$14.8K ﹤0.01% 1591

Other funds holding OFIX

FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing's OFIX Position: Q3 2026 in Review

GAMMA Investing increased its Orthofix Medical (OFIX) stake by 91% in Q3 2026, buying an estimated $4.83K and bringing the position to 987 shares worth $9.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3381.

GAMMA Investing first reported a position in OFIX in Q4 2023 and has held it in 12 quarters since. The position peaked at $23.7K in Q4 2024. 3 funds tracked by Wall St. Rank hold OFIX as of Q3 2026.

  • GAMMA Investing held 987 shares of Orthofix Medical worth $9.29K as of Q3 2026.
  • GAMMA Investing bought 469 Orthofix Medical shares in Q3 2026, an estimated $4.83K.
  • Orthofix Medical made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3381 holding.
  • GAMMA Investing first reported a position in Orthofix Medical in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Orthofix Medical position peaked at $23.7K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.